Cardiac Inflammation Research Group
1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
(
- Contribution to journal › Letter
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
-
Mark
A study of size-selective renal elimination using a novel human model
(
- Contribution to journal › Article
- 2023
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
-
Mark
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
(
- Contribution to journal › Article
-
Mark
Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta
(
- Contribution to journal › Article
-
Mark
Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article